Business

Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion

Published

on



Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to …

source

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version